Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure
- Status
- RECRUITING
- Phase
- PHASE4
Clinical Trials Related to Chronic Lymphocytic Leukaemia
Related studies linked through entity extraction aliases.
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
- Status
- RECRUITING
- Phase
- N/A
First in Human Study of NVG-111 in Relapsed/Refractory ROR1+ Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Outcomes and Routine Management of Adults With Chronic Lymphocytic Leukaemia Treated With Idelalisib and Rituximab in the United Kingdom (UK) and Ireland
- Status
- COMPLETED
- Phase
- N/A
BI-1206 and an Anti-CD20 Antibody in Patients With CD32b Positive B-cell Lymphoma or Leukaemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Tissue Collection for Biomarkers Determining Resistance to Ibrutinib
- Status
- UNKNOWN
- Phase
- N/A
Efficacy and Safety Study of Bendamustine With or Without Rituximab in Chronic Lymphoproliferative Disorders
- Status
- COMPLETED
- Phase
- N/A
A Phase I Trial of DI-B4 in Patients With Advanced CD19 Positive Indolent B-cell Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
A Trial Looking at Ofatumumab for People With Chronic Lymphocytic Leukaemia Who Cannot Have More Intensive Treatment
- Status
- UNKNOWN
- Phase
- PHASE3
Study to Evaluate the Safety and Tolerability of Tirabrutinib (ONO/GS-4059) Given as Monotherapy in Participants With Relapsed/Refractory NHL and CLL
- Status
- COMPLETED
- Phase
- PHASE1
Trial of Haploidentical Stem Cell Transplantation for Haematological Cancers
- Status
- COMPLETED
- Phase
- PHASE2
R-2cda and Prolongation of Therapy With Rituximab Alone in Chronic Lymphocytic Leukaemia and Small Lymphocytic Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
RESPeCT: Revlimid Early Stage Poor Prognosis Chronic Lymphocytic Leukaemia (CLL) Trial
- Status
- TERMINATED
- Phase
- PHASE2
Study of Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL)
- Status
- TERMINATED
- Phase
- PHASE2
R-CHOP and Alemtuzumab in Patients With Chronic Lymphocytic Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE2
A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
A Single-arm Phase II Study of Alemtuzumab in Combination With High-dose Methylprednisolone in CLL Patients With p53 Deletion
- Status
- COMPLETED
- Phase
- PHASE2